Marker Therapeutics Ownership 2024 | Who Owns Marker Therapeutics Now?


OverviewRevenueFinancialsChart

Institutional Ownership

0.79%

Insider Ownership

12.20%

Retail Ownership

87.01%

Institutional Holders

1.00

Marker Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AR ASSET MANAGEMENT INC0.79%0.09%70,700--384,000Jun 30, 2024

Marker Therapeutics's largest institutional shareholder is AR ASSET MANAGEMENT INC, holding 0.79% of the company's total share outstanding, currently valued at $384.00K. The top 10 institutional shareholders own together 0.79% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AR ASSET MANAGEMENT INC0.79%0.09%70,700--384,000Jun 30, 2024

The largest Marker Therapeutics shareholder by % of total assets is AR ASSET MANAGEMENT INC. The company owns 70.70K shares of Marker Therapeutics (MRKR), representing 0.09% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AR ASSET MANAGEMENT INC0.79%0.09%70,700--384,000Jun 30, 2024

As of Jun 30 2024, Marker Therapeutics's largest institutional buyer is AR ASSET MANAGEMENT INC. The company purchased 0.00 stocks of MRKR, valued at $384.00K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AR ASSET MANAGEMENT INC0.79%0.09%70,700--384,000Jun 30, 2024

As of Jun 30 2024, Marker Therapeutics's biggest institutional seller is AR ASSET MANAGEMENT INC. The company sold 0.00 shares of MRKR, valued at $384.00K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Marker Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.11%54,947--Mar 31, 2024
BRIDGEWAY FUNDS INC0.10%242,416--Mar 28, 2024
FIDELITY COMMONWEALTH TRUST0.02%65,462--Feb 29, 2024
VICTORY PORTFOLIOS0.01%445,930--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,003--Mar 31, 2024
ALPS ETF Trust0.01%98,455--Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.01%45,421--Mar 31, 2024
SSGA FUNDS0.01%2,645--Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,309--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%1,630,877--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%546,237--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%56,903--Mar 31, 2024
Investment Managers Series Trust II0.00%21,534--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.00%820--Mar 31, 2024
Calvert Variable Products, Inc.0.00%2,391--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%26,562--Feb 29, 2024
HC CAPITAL TRUST0.00%19,534--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%16,012--Mar 31, 2024
SunAmerica Specialty Series0.00%243--Apr 30, 2021
VANGUARD WORLD FUND0.00%70,989--Feb 29, 2024
RUSSELL INVESTMENT CO0.00%62,205--Jan 31, 2024
NORTHERN FUNDS0.00%18,088--Mar 28, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%82,125--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%4,870--Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%297,105--Mar 31, 2024
ProFunds0.00%661--Mar 31, 2024
TIAA-CREF FUNDS0.00%166,747--Mar 31, 2024
VALIC Co I0.00%14,457--Feb 29, 2024
ALLSPRING MASTER TRUST0.00%3,198--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%94,765--Feb 29, 2024
PENN SERIES FUNDS INC0.00%1,100--Mar 28, 2024
NATIONWIDE MUTUAL FUNDS0.00%4,372--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%4,374--Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%31,80015,900100.00%Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%6,452--Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%24,518--Mar 31, 2024
VANGUARD WELLINGTON FUND0.00%8,417--Feb 29, 2024
PACE SELECT ADVISORS TRUST0.00%6,111--Jan 31, 2024
T. Rowe Price Index Trust, Inc.0.00%371--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%462--Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%33,200--Mar 31, 2024
Dimensional ETF Trust0.00%5,437--Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,128--Feb 29, 2024
Dimensional ETF Trust0.00%4,378--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%3,294--Mar 31, 2024
EQ ADVISORS TRUST0.00%10,174--Mar 31, 2024
WILSHIRE MUTUAL FUNDS INC0.00%2,160--Dec 31, 2023
iSHARES TRUST0.00%108,538--Mar 31, 2024
Principal Exchange-Traded Funds0.00%64--Mar 31, 2024
PACIFIC SELECT FUND0.00%18,565--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%4,330--Dec 31, 2023
Bridge Builder Trust0.00%14,082--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%697--Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%2,986--Mar 31, 2024
BlackRock Variable Series Funds, Inc.0.00%3,653--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%3,821--Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%11,600--Feb 29, 2024
Advisors' Inner Circle Fund III0.00%18--Jan 31, 2024
BLACKROCK FUNDS0.00%1,128--Mar 28, 2024

Marker Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 54.95K shares, compromising 0.11% of its total assets.

Marker Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 241-
31 Mar, 241-
31 Dec, 231-
30 Sep, 231-
30 Jun, 231-50.00%
31 Mar, 232-95.35%
31 Dec, 224313.16%
30 Sep, 2238-11.63%
30 Jun, 2243-8.51%
31 Mar, 2247-22.95%
31 Dec, 2161-6.15%
30 Sep, 2165-13.33%
30 Jun, 2175-2.60%
31 Mar, 217726.23%
31 Dec, 20611.67%
30 Sep, 2060-9.09%
30 Jun, 20661.54%
31 Mar, 2065-7.14%
31 Dec, 1970-11.39%
30 Sep, 19796.76%
30 Jun, 197434.55%
31 Mar, 195525.00%
31 Dec, 18444300.00%
30 Sep, 181-

As of 30 Jun 24, 1 institutions are holding Marker Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2470,700-
31 Mar, 2470,700-
31 Dec, 2370,700-
30 Sep, 2370,70073.71%
30 Jun, 2340,700-88.53%
31 Mar, 23354,986-98.18%
31 Dec, 2219,537,213-4.37%
30 Sep, 2220,430,222-8.20%
30 Jun, 2222,254,399-4.50%
31 Mar, 2223,303,937-11.81%
31 Dec, 2126,423,2020.14%
30 Sep, 2126,386,060-2.68%
30 Jun, 2127,113,5696.74%
31 Mar, 2125,401,65480.33%
31 Dec, 2014,085,831-0.31%
30 Sep, 2014,130,285-0.53%
30 Jun, 2014,205,458-4.63%
31 Mar, 2014,895,685-4.24%
31 Dec, 1915,555,854-9.76%
30 Sep, 1917,237,413-6.12%
30 Jun, 1918,361,95020.01%
31 Mar, 1915,300,101-1.77%
31 Dec, 1815,576,264437067.11%
30 Sep, 183,563-

Marker Therapeutics (MRKR) has 70.70K shares outstanding as of 30 Jun 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 240.79%125.86%
31 Mar, 240.79%123.79%
31 Dec, 230.80%124.07%
30 Sep, 230.80%368.91%
30 Jun, 230.47%2.82%
31 Mar, 234.07%0.24%
31 Dec, 2241.53%2.20%
30 Sep, 2243.43%1.94%
30 Jun, 2247.31%1.93%
31 Mar, 2249.54%2.26%
31 Dec, 2146.79%2.14%
30 Sep, 2146.73%2.03%
30 Jun, 2148.01%2.37%
31 Mar, 2144.98%4.98%
31 Dec, 2030.05%3.31%
30 Sep, 2030.15%3.24%
30 Jun, 2030.50%2.92%
31 Mar, 2032.32%2.78%
31 Dec, 1934.12%2.39%
30 Sep, 1937.76%2.32%
30 Jun, 1940.35%3.56%
31 Mar, 1933.65%2.87%
31 Dec, 1834.26%56047065.38%
30 Sep, 180.01%-

As of 30 Jun 24, Marker Therapeutics is held by 0.79% institutional shareholders, representing a 125.86% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--100.00%
30 Sep, 231-
30 Jun, 23--100.00%
31 Mar, 231-95.00%
31 Dec, 2220150.00%
30 Sep, 228-
30 Jun, 228-46.67%
31 Mar, 2215-16.67%
31 Dec, 211820.00%
30 Sep, 2115-51.61%
30 Jun, 2131-26.19%
31 Mar, 214268.00%
31 Dec, 202525.00%
30 Sep, 2020-33.33%
30 Jun, 203030.43%
31 Mar, 2023-28.13%
31 Dec, 1932-23.81%
30 Sep, 1942-8.70%
30 Jun, 194639.39%
31 Mar, 1933-23.26%
31 Dec, 18434200.00%
30 Sep, 181-

- institutional shareholders have increased their position in MRKR stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 231-83.33%
31 Dec, 226-33.33%
30 Sep, 229-30.77%
30 Jun, 221318.18%
31 Mar, 2211-59.26%
31 Dec, 21273.85%
30 Sep, 21268.33%
30 Jun, 212450.00%
31 Mar, 2116-
31 Dec, 2016-11.11%
30 Sep, 201838.46%
30 Jun, 2013-43.48%
31 Mar, 202343.75%
31 Dec, 191645.45%
30 Sep, 1911-
30 Jun, 191183.33%
31 Mar, 196-
31 Dec, 18--
30 Sep, 18--

- institutional shareholders have reduced their position in MRKR stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 241-70,700-0.79%125.86%----
31 Mar, 241-70,700-0.79%123.79%----
31 Dec, 231-70,700-0.80%124.07%--100.00%--
30 Sep, 231-70,70073.71%0.80%368.91%1---
30 Jun, 231-50.00%40,700-88.53%0.47%2.82%--100.00%--100.00%
31 Mar, 232-95.35%354,986-98.18%4.07%0.24%1-95.00%1-83.33%
31 Dec, 224313.16%19,537,213-4.37%41.53%2.20%20150.00%6-33.33%
30 Sep, 2238-11.63%20,430,222-8.20%43.43%1.94%8-9-30.77%
30 Jun, 2243-8.51%22,254,399-4.50%47.31%1.93%8-46.67%1318.18%
31 Mar, 2247-22.95%23,303,937-11.81%49.54%2.26%15-16.67%11-59.26%
31 Dec, 2161-6.15%26,423,2020.14%46.79%2.14%1820.00%273.85%
30 Sep, 2165-13.33%26,386,060-2.68%46.73%2.03%15-51.61%268.33%
30 Jun, 2175-2.60%27,113,5696.74%48.01%2.37%31-26.19%2450.00%
31 Mar, 217726.23%25,401,65480.33%44.98%4.98%4268.00%16-
31 Dec, 20611.67%14,085,831-0.31%30.05%3.31%2525.00%16-11.11%
30 Sep, 2060-9.09%14,130,285-0.53%30.15%3.24%20-33.33%1838.46%
30 Jun, 20661.54%14,205,458-4.63%30.50%2.92%3030.43%13-43.48%
31 Mar, 2065-7.14%14,895,685-4.24%32.32%2.78%23-28.13%2343.75%
31 Dec, 1970-11.39%15,555,854-9.76%34.12%2.39%32-23.81%1645.45%
30 Sep, 19796.76%17,237,413-6.12%37.76%2.32%42-8.70%11-
30 Jun, 197434.55%18,361,95020.01%40.35%3.56%4639.39%1183.33%
31 Mar, 195525.00%15,300,101-1.77%33.65%2.87%33-23.26%6-
31 Dec, 18444300.00%15,576,264437067.11%34.26%56047065.38%434200.00%--
30 Sep, 181-3,563-0.01%-1---

Marker Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 08, 2023Eansor Norman Daviddirector-P-PurchaseBuy14,285$17.50$249.99K16,713

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 08, 2023Eansor Norman Daviddirector-P-PurchaseBuy14,285$17.50$249.99K16,713

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 08, 2023Eansor Norman Daviddirector-G-GiftSell14,285--2,428

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 05, 2023Lurier Eliot Mofficer-Buy----
Jun 08, 2023Eansor Norman Daviddirector-P-PurchaseBuy14,285$17.50$249.99K16,713
Jun 08, 2023Eansor Norman Daviddirector-A-AwardBuy8,000$1.72$13.76K8,000
Jun 08, 2023Eansor Norman Daviddirector-G-GiftBuy7,142--7,142
Jun 08, 2023Eansor Norman Daviddirector-G-GiftSell14,285--2,428
Jun 08, 2023Knobil Katharinedirector-A-AwardBuy8,000$1.72$13.76K8,000
Jun 08, 2023Wilson John Robertdirector-A-AwardBuy8,000$1.72$13.76K8,000
Jun 08, 2023ELMS STEVEdirector-A-AwardBuy8,000$1.72$13.76K8,000
May 11, 2023Vera Juandirector, officer President and CEOA-AwardBuy100,000$1.42$142.00K100,000
Mar 01, 2023Hoang Tsvetelina Pofficer VP, Research and DevelopmentA-AwardBuy33,159$2.14$70.96K33,159
Mar 01, 2023Koneru Mythiliofficer Chief Medical OfficerA-AwardBuy51,918$2.14$111.10K51,918
Mar 01, 2023Loiacono Michaelofficer Chief Accounting OfficerA-AwardBuy38,480$2.14$82.35K38,480
Mar 01, 2023Vera Juandirector, officer Chief Scientific Officer & COOA-AwardBuy46,487$2.14$99.48K46,487
Mar 01, 2023Szymanska Annaofficer Vice President, QualityA-AwardBuy29,947$2.14$64.09K29,947
Mar 01, 2023Agopyan Nadiaofficer SVP, Regulatory AffairsA-AwardBuy34,154$2.14$73.09K34,154
May 26, 2022Wilson John Robertdirector A-AwardBuy80,000--80,000
May 26, 2022Laskow-Pooley Daviddirector A-AwardBuy80,000--80,000
May 26, 2022Knobil Katharinedirector A-AwardBuy80,000--80,000
May 26, 2022Knobil Katharinedirector-A-AwardBuy80,000$0.34$27.02K80,000
May 26, 2022ELMS STEVEdirector A-AwardBuy80,000--80,000

The last insider sell of Marker Therapeutics's stock was made by Eansor Norman David on Jun 08 2023, selling 14,285 shares at - per share (valued at -). The last insider buy of MRKR was made by Eansor Norman David on Jun 08 2023, buying 14,285 shares at $17.50 per share (worth $249.99K).

Marker Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20231--
Q1 20236--
Q2 20225--
Q1 2022123400.00%
Q4 20211--
Q2 20216--
Q1 202123--
Q4 2020---
Q2 2020-1-
Q1 2020194475.00%
Q3 20193--
Q2 201941400.00%
Q4 20181312108.33%
Q3 20181--
Q2 20181--
Q1 20187--
Q3 201772350.00%
Q1 20172--
Q4 201632150.00%
Q3 201661600.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Marker Therapeutics's insiders, as of Q2 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2023---
Q1 2023---
Q2 2022---
Q1 2022---
Q4 2021---
Q2 20211--
Q1 202114--
Q4 2020---
Q2 2020---
Q1 2020---
Q3 20191--
Q2 2019---
Q4 2018---
Q3 2018---
Q2 20181--
Q1 2018---
Q3 2017---
Q1 2017---
Q4 2016---
Q3 2016---

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Marker Therapeutics's stocks.

Marker Therapeutics Peer Ownership


TickerCompany
PMVPPMV Pharmaceuticals, Inc.
IKNAIkena Oncology, Inc.
XCURExicure, Inc.
EWTXEdgewise Therapeutics, Inc.
ALECAlector, Inc.
AVTEAerovate Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
KROSKeros Therapeutics, Inc.
AGENAgenus Inc.
RNXTRenovoRx, Inc.
TPSTTempest Therapeutics, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
BNOXBionomics Limited
PTIXProtagenic Therapeutics, Inc.
CBIOGyre Therapeutics, Inc.
AADIAadi Bioscience, Inc.
LUMOLumos Pharma, Inc.

MRKR Ownership FAQ


Marker Therapeutics is owned by institutional shareholders (0.79%), insiders (12.20%), and public (87.01%). The largest institutional shareholder of Marker Therapeutics is AR ASSET MANAGEMENT INC (0.79% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.11% of total shares).

Marker Therapeutics's major institutional shareholders are AR ASSET MANAGEMENT INC. The top five shareholders own together 0.79% of the company's share outstanding.

As of Jun 2024, there are 1 institutional shareholders of Marker Therapeutics.

AR ASSET MANAGEMENT INC owns 70.7K shares of Marker Therapeutics, representing 0.79% of the company's total shares outstanding, valued at $384K (as of Jun 2024).